In 2023, the share of scientific publications in the top 10% of cited publications in endocrinology for Brazil stood at 4.85%. From 2024 to 2028, projections suggest a steady decline, ending at 4.83% in 2028. This indicates a minor year-on-year decline starting from 2026, with a consistent decrease of -0.01% annually from 2026 to 2028. Over the five-year forecast period, the Compound Annual Growth Rate (CAGR) is negligible, suggesting stability with slight downward pressure.
Future trends to watch for:
- The impact of international collaborations and funding on increasing the citation impact of Brazilian endocrinology research.
- The role of innovation-driven research and emerging technologies in potentially reversing the downward trend.
- Policy and strategy changes within Brazil's scientific community to enhance publication quality and citation metrics.
